The board of directors of Jilin Province Huinan Changlong Bio-pharmacy Company Limited, and together with its subsidiaries, collectively hereby announces that, the auditors of the Company could not conduct the relevant audit field works in the People's Republic of China (the "PRC") for the audit of the consolidated financial statements of the Group for the year ended 31 December 2019 under the current outbreak of novel coronavirus (COVID-19) epidemic (the "Epidemic") that many provinces and municipalities in the PRC have implemented travel restrictions and border control measures and mandatory medical surveillance for 14 days for people arriving from areas with active community transmission of the Epidemic. This will inevitably cause delay in the publication and despatch of the audited annual results announcement and the annual report of the Group for the year ended 31 December 2019. However, in order to keep the shareholders of the Company and the public informed of the Group's business operation and financial position, the Board has decided to publish the unaudited annual results announcement of the Company for the year ended 31 December 2019 on 31 March 2020.